About Peter Kirkpatrick
As Chief Editor of one of the two journals in which BioPharma Dealmakers appears, I have a keen interest in the process of translating biomedical research into new drugs, including the partnerships that play a key role in this process.
CEO & Co-Founder, Zapnito
Former Head of Communities, Springer Nature
Managing Director, Thoroughly Good Consulting
Sales Account Executive, Springer Nature
Editor, BioPharma Dealmakers , Nature Publishing Group